MP-4-CO

N/A

Report date: 2022/11/25 18:07:48

Base Information

Drug NameMP-4-CO

Drug Alias NameCarbon monoxide-carrying pegylated haemoglobin - SangartPEG carboxyhaemoglobinPegylated carboxyhaemoglobinCarbon monoxide-carrying colloid - SangartMP-4-CO

ClassificationBiologics

Mechanisms of ActionHemoglobins modulators

TargetsHemoglobins

Therapy Area/IndicationsHemoglobin SC DiseaseAnemia, Sickle Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumNetherlandsTurkey +[10]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesSangart Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSangart Inc

Active IndicationsN/A

Inactive IndicationsHemoglobin SC DiseaseAnemia, Sickle Cell

Other Information

ATC CodeN/A